China Resources Pharmaceutical Group Limited 3320.HK Stock
China Resources Pharmaceutical Group Limited Price Chart
China Resources Pharmaceutical Group Limited 3320.HK Financial and Trading Overview
Contents
- China Resources Pharmaceutical Group Limited Price Chart
- China Resources Pharmaceutical Group Limited 3320.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of China Resources Pharmaceutical Group Limited
- Q&A For China Resources Pharmaceutical Group Limited Stock
| China Resources Pharmaceutical Group Limited stock price | 4.72 HKD |
| Previous Close | 6.91 HKD |
| Open | 7.04 HKD |
| Bid | 7.03 HKD x 0 |
| Ask | 7.04 HKD x 0 |
| Day's Range | 6.86 - 7.05 HKD |
| 52 Week Range | 4.34 - 8.13 HKD |
| Volume | 8.36M HKD |
| Avg. Volume | 9.67M HKD |
| Market Cap | 44.23B HKD |
| Beta (5Y Monthly) | 0.429885 |
| PE Ratio (TTM) | 11.354838 |
| EPS (TTM) | 0.66 HKD |
| Forward Dividend & Yield | 0.16 (2.18%) |
| Ex-Dividend Date | June 5, 2023 |
| 1y Target Est | 8.24 HKD |
3320.HK Valuation Measures
| Enterprise Value | 121.74B HKD |
| Trailing P/E | 11.354838 |
| Forward P/E | 8.481928 |
| PEG Ratio (5 yr expected) | 0.49 |
| Price/Sales (ttm) | 0.17405652 |
| Price/Book (mrq) | 0.8924949 |
| Enterprise Value/Revenue | 0.479 |
| Enterprise Value/EBITDA | 8.748 |
Trading Information
China Resources Pharmaceutical Group Limited Stock Price History
| Beta (5Y Monthly) | 0.429885 |
| 52-Week Change | 42.18% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.13 HKD |
| 52 Week Low | 4.34 HKD |
| 50-Day Moving Average | 7.22 HKD |
| 200-Day Moving Average | 6.42 HKD |
3320.HK Share Statistics
| Avg. Volume (3 month) | 9.67M HKD |
| Avg. Daily Volume (10-Days) | 6.08M HKD |
| Shares Outstanding | 6.28B |
| Float | 1.69B |
| Short Ratio | N/A |
| % Held by Insiders | 73.69% |
| % Held by Institutions | 6.48% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.16 |
| Trailing Annual Dividend Yield | 2.31% |
| 5 Year Average Dividend Yield | 221.00% |
| Payout Ratio | 0.22729999 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 1.63% |
| Operating Margin (ttm) | 4.50% |
| Gross Margin | 15.40% |
| EBITDA Margin | 5.47% |
Management Effectiveness
| Return on Assets (ttm) | 2.91% |
| Return on Equity (ttm) | 8.47% |
Income Statement
| Revenue (ttm) | 254.11B HKD |
| Revenue Per Share (ttm) | 40.45 HKD |
| Quarterly Revenue Growth (yoy) | 5.00% |
| Gross Profit (ttm) | 39.13B HKD |
| EBITDA | 13.92B HKD |
| Net Income Avi to Common (ttm) | 4.15B HKD |
| Diluted EPS (ttm) | 0.62 |
| Quarterly Earnings Growth (yoy) | -15.69% |
Balance Sheet
| Total Cash (mrq) | 25.45B HKD |
| Total Cash Per Share (mrq) | 4.05 HKD |
| Total Debt (mrq) | 63.16B HKD |
| Total Debt/Equity (mrq) | 70.03 HKD |
| Current Ratio (mrq) | 1.25 |
| Book Value Per Share (mrq) | 7.888 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 12.63B HKD |
| Levered Free Cash Flow (ttm) | 10.12B HKD |
Profile of China Resources Pharmaceutical Group Limited
| Country | Hong Kong |
| State | N/A |
| City | Wan Chai |
| Address | China Resources Building |
| ZIP | N/A |
| Phone | 852 2593 8991 |
| Website | https://www.crpharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 67000 |
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Q&A For China Resources Pharmaceutical Group Limited Stock
What is a current 3320.HK stock price?
China Resources Pharmaceutical Group Limited 3320.HK stock price today per share is 4.72 HKD.
How to purchase China Resources Pharmaceutical Group Limited stock?
You can buy 3320.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for China Resources Pharmaceutical Group Limited?
The stock symbol or ticker of China Resources Pharmaceutical Group Limited is 3320.HK.
Which industry does the China Resources Pharmaceutical Group Limited company belong to?
The China Resources Pharmaceutical Group Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does China Resources Pharmaceutical Group Limited have in circulation?
The max supply of China Resources Pharmaceutical Group Limited shares is 6.28B.
What is China Resources Pharmaceutical Group Limited Price to Earnings Ratio (PE Ratio)?
China Resources Pharmaceutical Group Limited PE Ratio is 7.15151450 now.
What was China Resources Pharmaceutical Group Limited earnings per share over the trailing 12 months (TTM)?
China Resources Pharmaceutical Group Limited EPS is 0.66 HKD over the trailing 12 months.
Which sector does the China Resources Pharmaceutical Group Limited company belong to?
The China Resources Pharmaceutical Group Limited sector is Healthcare.